Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo.

Golovine K, Makhov P, Uzzo RG, Shaw T, Kunkle D, Kolenko VM.

Clin Cancer Res. 2008 Sep 1;14(17):5376-84. doi: 10.1158/1078-0432.CCR-08-0455.

2.

Zinc and prostatic cancer.

Ho E, Song Y.

Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):640-5. doi: 10.1097/MCO.0b013e32833106ee. Review.

3.
4.

Zinc as an anti-tumor agent in prostate cancer and in other cancers.

Franklin RB, Costello LC.

Arch Biochem Biophys. 2007 Jul 15;463(2):211-7. Epub 2007 Mar 16. Review.

5.

A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Costello LC, Franklin RB.

Arch Biochem Biophys. 2016 Dec 1;611:100-112. doi: 10.1016/j.abb.2016.04.014. Epub 2016 Apr 27. Review.

6.

Zinc transporters in prostate cancer.

Franz MC, Anderle P, B├╝rzle M, Suzuki Y, Freeman MR, Hediger MA, Kovacs G.

Mol Aspects Med. 2013 Apr-Jun;34(2-3):735-41. doi: 10.1016/j.mam.2012.11.007. Review.

7.

Zinc and zinc transporters in prostate carcinogenesis.

Kolenko V, Teper E, Kutikov A, Uzzo R.

Nat Rev Urol. 2013 Apr;10(4):219-26. doi: 10.1038/nrurol.2013.43. Epub 2013 Mar 12. Review.

Supplemental Content

Support Center